# TYGACIL
> **NDA021821** · New Drug Application · Sponsor: PF PRISM CV · Approved 2005-06-15
## Drug
- **FDA Application Number:** NDA021821
- **Application type:** New Drug Application
- **Brand name:** TYGACIL
- **Generic name:** TIGECYCLINE
- **Active ingredients:** TIGECYCLINE
- **Dosage form:** POWDER
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** PF PRISM CV
- **Manufacturer:** Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.
- **First approval:** 2005-06-15
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021821)
---
*MORVS · CC0 1.0*